Researchers identify novel class of drugs for prostate cancers

May 28, 2013 – A research team led by Ganesh Raj, M.D., Ph.D., developed a novel class of drugs that interrupts critical signaling needed for prostate cancer cells to grow. Their study appeared in Nature Communications.

UT Southwestern issued a news release about the work.